These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36892308)

  • 1. The Cystic Fibrosis Upper and Lower Airway Metagenome.
    Pienkowska K; Pust MM; Gessner M; Gaedcke S; Thavarasa A; Rosenboom I; Morán Losada P; Minso R; Arnold C; Hedtfeld S; Dorda M; Wiehlmann L; Mainz JG; Klockgether J; Tümmler B
    Microbiol Spectr; 2023 Mar; 11(2):e0363322. PubMed ID: 36892308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome.
    Pallenberg ST; Pust MM; Rosenboom I; Hansen G; Wiehlmann L; Dittrich AM; Tümmler B
    Microbiol Spectr; 2022 Oct; 10(5):e0145422. PubMed ID: 36154176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metagenome - Inferred bacterial replication rates in cystic fibrosis airways.
    Pienkowska K; Wiehlmann L; Tümmler B
    J Cyst Fibros; 2019 Sep; 18(5):653-656. PubMed ID: 30685331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cystic fibrosis lower airways microbial metagenome.
    Moran Losada P; Chouvarine P; Dorda M; Hedtfeld S; Mielke S; Schulz A; Wiehlmann L; Tümmler B
    ERJ Open Res; 2016 Apr; 2(2):. PubMed ID: 27730195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum metagenomics of people with bronchiectasis.
    Rosenboom I; Thavarasa A; Richardson H; Long MB; Wiehlmann L; Davenport CF; Shoemark A; Chalmers JD; Tümmler B
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38444657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics.
    McDermott G; Walsh A; Crispie F; Frost S; Greally P; Cotter PD; O'Sullivan O; Renwick J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
    Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
    mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy.
    Hilliam Y; Armbruster CR; Rapsinski GJ; Marshall CW; Moore J; Koirala J; Krainz L; Gaston JR; Cooper VS; Lee SE; Bomberger JM
    Microbiol Spectr; 2024 Aug; 12(8):e0078724. PubMed ID: 38916354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
    Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
    Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation.
    Hahn A; Burrell A; Ansusinha E; Peng D; Chaney H; Sami I; Perez GF; Koumbourlis AC; McCarter R; Freishtat RJ; Crandall KA; Zemanick ET
    Heliyon; 2020 Jun; 6(6):e04104. PubMed ID: 32514485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
    Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
    PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 17. Same Game, Different Players: Emerging Pathogens of the CF Lung.
    Gannon AD; Darch SE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436426
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
    J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist.
    Nichols DP; Morgan SJ; Skalland M; Vo AT; Van Dalfsen JM; Singh SB; Ni W; Hoffman LR; McGeer K; Heltshe SL; Clancy JP; Rowe SM; Jorth P; Singh PK;
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36976651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J; McNally P; John B; DeSantis T; Linnane B; Murphy P;
    PLoS One; 2014; 9(12):e109798. PubMed ID: 25526264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.